William Blair & Company’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-18,500
Closed -$78K 1845
2022
Q3
$78K Hold
18,500
﹤0.01% 1538
2022
Q2
$52K Hold
18,500
﹤0.01% 1625
2022
Q1
$106K Hold
18,500
﹤0.01% 1629
2021
Q4
$169K Hold
18,500
﹤0.01% 1614
2021
Q3
$198K Hold
18,500
﹤0.01% 1510
2021
Q2
$287K Hold
18,500
﹤0.01% 1358
2021
Q1
$300K Hold
18,500
﹤0.01% 1331
2020
Q4
$392K Hold
18,500
﹤0.01% 1161
2020
Q3
$274K Hold
18,500
﹤0.01% 1174
2020
Q2
$272K Buy
+18,500
New +$272K ﹤0.01% 1137